Theoretically-derived molecular descriptors important in human intestinal absorption

被引:63
作者
Agatonovic-Kustrin, S [1 ]
Beresford, R
Yusof, APM
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, Penang 11800, Malaysia
[2] Univ Otago, Sch Pharm, Dunedin, New Zealand
关键词
human intestinal absorption; molecular descriptors; ANN; GNN;
D O I
10.1016/S0731-7085(00)00492-1
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A quantitative structure-human intestinal absorption relationship was developed using artificial neural network (ANN) modeling. A set of 86 drug compounds and their experimentally-derived intestinal absorption values used in this study was gathered from the literature and a total of 57 global molecular descriptors, including constitutional, topological, chemical, geometrical and quantum chemical descriptors, calculated For each compound. A supervised network with radial basis transfer function was used to correlate calculated molecular descriptors with experimentally-derived measures of human intestinal absorption. A genetic algorithm was then used to select important molecular descriptors. Intestinal absorption values (IA%) were used as the ANN's output and calculated molecular descriptors as the inputs. The best genetic neural network (GNN) model with 15 input descriptors was chosen, and the significance of the selected descriptors for intestinal absorption examined. Results obtained with the model that was developed indicate that lipophilicity, conformational stability and inter-molecular interactions (polarity, and hydrogen bonding) have the largest impact on intestinal absorption. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:227 / 237
页数:11
相关论文
共 26 条
[1]   ESTIMATING HUMAN ORAL FRACTION DOSE ABSORBED - A CORRELATION USING RAT INTESTINAL-MEMBRANE PERMEABILITY FOR PASSIVE AND CARRIER-MEDIATED COMPOUNDS [J].
AMIDON, GL ;
SINKO, PJ ;
FLEISHER, D .
PHARMACEUTICAL RESEARCH, 1988, 5 (10) :651-654
[2]   Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond [J].
Artursson, P ;
Borchardt, RT .
PHARMACEUTICAL RESEARCH, 1997, 14 (12) :1655-1658
[3]   Caco-2 monolayers in experimental and theoretical predictions of drug transport [J].
Artursson, P ;
Palm, K ;
Luthman, K .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 22 (1-2) :67-84
[4]   EVIDENCE FOR GLUCURONIDE CONJUGATION OF PARA-NITROPHENOL IN THE CACO-2 CELL MODEL [J].
BJORGE, S ;
HAMELEHLE, KL ;
HOMAN, R ;
ROSE, SE ;
TURLUCK, DA ;
WRIGHT, DS .
PHARMACEUTICAL RESEARCH, 1991, 8 (11) :1441-1443
[5]   SOME PHYSICO-CHEMICAL FACTORS IN DRUG ACTION [J].
BRODIE, BB ;
HOGBEN, CAM .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1957, 9 (06) :345-380
[6]  
Farnum MA, 1999, BIOPHYS J, V76, pA127
[7]   Design of immuno-enzymosomes with maximum enzyme targeting capability: effect of the enzyme density on the enzyme targeting capability and cell binding properties [J].
Fonseca, MJ ;
Haisma, HJ ;
Klaasen, S ;
Vingerhoeds, MH ;
Storm, G .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1419 (02) :272-282
[8]  
HOGEN CAM, 1959, J PHARMACOL EXP THER, V125, P275
[9]  
INUI K, 1992, J PHARMACOL EXP THER, V261, P195
[10]   A contribution to safety assessment of veterinary drug residues:: in vitro/ex vivo studies on the intestinal toxicity and transport of covalently bound residues [J].
Klee, S ;
Baumung, I ;
Kluge, K ;
Ungemach, FR ;
Horne, E ;
O'Keeffe, M ;
De Angelis, I ;
Vignoli, AL ;
Zucco, F ;
Stammati, A .
XENOBIOTICA, 1999, 29 (06) :641-654